Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Tyra Biosciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +26 vs. Q2 2021
- Shares held
- 26.1M
- +26.1M vs. Q2 2021
- Total value
- $456.8M
- +$456.8M vs. Q2 2021
- New holders
- 26
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Red Tortoise LLC | 212 | $2.00K | 0.00% | +212 | New |
| Citigroup Inc | 440 | $8.00K | 0.00% | +440 | New |
| Bank of America Corp | 885 | $15.0K | 0.00% | +885 | New |
| Maven Securities LTD | 10,140 | $178.0K | 0.02% | +10,140 | New |
| Qube Research & Technologies Ltd | 11,456 | $202.0K | 0.00% | +11,456 | New |
| Samson Rock Capital LLP | 15,267 | $269.0K | 0.17% | +15,267 | New |
| Pinz Capital Management, LP | 27,700 | $487.0K | 0.22% | +27,700 | New |
| HRT Financial LP | 31,805 | $559.0K | 0.00% | +31,805 | New |
| LMR Partners LLP | 54,000 | $950.0K | 0.01% | +54,000 | New |
| Millennium Management LLC | 93,501 | $1.65M | 0.00% | +93,501 | New |
| Ensign Peak Advisors, Inc | 125,000 | $2.20M | 0.00% | +125,000 | New |
| Goldman Sachs Group Inc | 207,283 | $3.65M | 0.00% | +207,283 | New |
| Woodline Partners LP | 366,035 | $6.44M | 0.11% | +366,035 | New |
| Jennison Associates LLC | 468,750 | $8.24M | 0.01% | +468,750 | New |
| Fairmount Funds Management LLC | 499,040 | $8.78M | 3.19% | +499,040 | New |
| Deerfield Management Company, L.P. (Series C) | 625,000 | $11.0M | 0.21% | +625,000 | New |
| Wellington Management Group LLP | 695,371 | $12.2M | 0.00% | +695,371 | New |
| Perceptive Advisors LLC | 987,500 | $17.4M | 0.25% | +987,500 | New |
| Logos Global Management LP | 1,003,394 | $17.6M | 1.27% | +1,003,394 | New |
| Cormorant Asset Management, LP | 1,069,932 | $18.2M | 0.74% | +1,069,932 | New |
| Frazier Management LLC | 1,250,000 | $22.0M | 1.76% | +1,250,000 | New |
| Janus Henderson Group PLC | 1,374,648 | $22.8M | 0.01% | +1,374,648 | New |
| BVF Inc | 1,694,933 | $29.8M | 1.16% | +1,694,933 | New |
| FMR LLC | 1,908,659 | $33.6M | 0.00% | +1,908,659 | New |
| Boxer Capital, LLC | 6,323,359 | $111.2M | 3.88% | +6,323,359 | New |
| Ra Capital Management, L.P. | 7,236,454 | $127.3M | 1.76% | +7,236,454 | New |